Class information for:
Level 1: DYSKINESIA//LEVODOPA//MOTOR FLUCTUATIONS

Basic class information

Class id #P Avg. number of
references
Database coverage
of references
372 3571 44.8 73%



Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes

The table includes all classes above and classes immediately below the current class.



Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
124 3       PARKINSONS DISEASE//MOVEMENT DISORDERS//DEEP BRAIN STIMULATION 67777
166 2             PARKINSONS DISEASE//MOVEMENT DISORDERS//MULTIPLE SYSTEM ATROPHY 22593
372 1                   DYSKINESIA//LEVODOPA//MOTOR FLUCTUATIONS 3571

Terms with highest relevance score



rank Term termType Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
1 DYSKINESIA authKW 2047278 15% 43% 552
2 LEVODOPA authKW 1328519 14% 30% 512
3 MOTOR FLUCTUATIONS authKW 1017245 5% 62% 193
4 PARKINSONS DISEASE authKW 599988 41% 5% 1451
5 DOPAMINE AGONISTS authKW 505126 7% 23% 261
6 MOTOR COMPLICATIONS authKW 486731 2% 65% 88
7 L DOPA authKW 465735 8% 19% 288
8 L DOPA INDUCED DYSKINESIA authKW 290447 2% 59% 58
9 ROPINIROLE authKW 278949 2% 40% 82
10 CONTINUOUS DOPAMINERGIC STIMULATION authKW 276347 1% 79% 41

Web of Science journal categories



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
1 Clinical Neurology 63403 57% 0% 2053
2 Neurosciences 11622 34% 0% 1219
3 Pharmacology & Pharmacy 5566 25% 0% 880
4 Psychiatry 846 7% 0% 236
5 Medicine, General & Internal 284 6% 0% 209
6 Geriatrics & Gerontology 164 1% 0% 51
7 Behavioral Sciences 37 1% 0% 43
8 Primary Health Care 6 0% 0% 8
9 Chemistry, Medicinal 2 1% 0% 37
10 Medicine, Research & Experimental 0 1% 0% 50

Address terms



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 BASAL GANGLIA PATHOPHYSIOL UNIT 189944 1% 56% 40
2 MANCHESTER MOVEMENT DISORDER 57779 0% 52% 13
3 EXPT THER EUT BRANCH 43284 1% 16% 32
4 MOVEMENT DISORDER CLIN 39732 1% 23% 20
5 PARKINSONS DIS MOVEMENT DISORDERS 35334 1% 12% 36
6 SERV NEUROL NEUROL EXPT 34196 0% 100% 4
7 NEUROL 28086 26% 0% 915
8 CIC9302 27919 0% 47% 7
9 CLIN INVEST CIC9302 25647 0% 100% 3
10 NDRG 25647 0% 100% 3

Journals



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with
term in
class
1 CLINICAL NEUROPHARMACOLOGY 198884 7% 10% 236
2 MOVEMENT DISORDERS 126836 9% 5% 311
3 PARKINSONISM & RELATED DISORDERS 39269 3% 4% 105
4 NEUROLOGY 37854 9% 1% 307
5 JOURNAL OF NEURAL TRANSMISSION 15752 2% 2% 87
6 AKTUELLE NEUROLOGIE 15459 2% 3% 57
7 ANNALS OF NEUROLOGY 9168 3% 1% 92
8 JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT 8419 1% 4% 28
9 EUROPEAN NEUROLOGY 6691 1% 1% 53
10 ADVANCES IN NEUROLOGY 6667 1% 4% 20

Author Key Words



Rank Term Chi square Shr. of publ. in
class containing
term
Class's shr. of
term's tot. occurrences
#P with term
in class
LCSH search Wikipedia search
1 DYSKINESIA 2047278 15% 43% 552 Search DYSKINESIA Search DYSKINESIA
2 LEVODOPA 1328519 14% 30% 512 Search LEVODOPA Search LEVODOPA
3 MOTOR FLUCTUATIONS 1017245 5% 62% 193 Search MOTOR+FLUCTUATIONS Search MOTOR+FLUCTUATIONS
4 PARKINSONS DISEASE 599988 41% 5% 1451 Search PARKINSONS+DISEASE Search PARKINSONS+DISEASE
5 DOPAMINE AGONISTS 505126 7% 23% 261 Search DOPAMINE+AGONISTS Search DOPAMINE+AGONISTS
6 MOTOR COMPLICATIONS 486731 2% 65% 88 Search MOTOR+COMPLICATIONS Search MOTOR+COMPLICATIONS
7 L DOPA 465735 8% 19% 288 Search L+DOPA Search L+DOPA
8 L DOPA INDUCED DYSKINESIA 290447 2% 59% 58 Search L+DOPA+INDUCED+DYSKINESIA Search L+DOPA+INDUCED+DYSKINESIA
9 ROPINIROLE 278949 2% 40% 82 Search ROPINIROLE Search ROPINIROLE
10 CONTINUOUS DOPAMINERGIC STIMULATION 276347 1% 79% 41 Search CONTINUOUS+DOPAMINERGIC+STIMULATION Search CONTINUOUS+DOPAMINERGIC+STIMULATION

Core articles

The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.



Rank Reference # ref. in
cl.
Shr. of ref. in
cl.
Citations
1 HUOT, P , JOHNSTON, TH , KOPRICH, JB , FOX, SH , BROTCHIE, JM , (2013) THE PHARMACOLOGY OF L-DOPA-INDUCED DYSKINESIA IN PARKINSON'S DISEASE.PHARMACOLOGICAL REVIEWS. VOL. 65. ISSUE 1. P. 171 -222 282 50% 79
2 BASTIDE, MF , MEISSNER, WG , PICCONI, B , FASANO, S , FERNAGUT, PO , FEYDER, M , FRANCARDO, V , ALCACER, C , DING, YM , BRAMBILLA, R , ET AL (2015) PATHOPHYSIOLOGY OF L-DOPA-INDUCED MOTOR AND NON-MOTOR COMPLICATIONS IN PARKINSON'S DISEASE.PROGRESS IN NEUROBIOLOGY. VOL. 132. ISSUE . P. 96 -168 343 34% 25
3 SCHAEFFER, E , PILOTTO, A , BERG, D , (2014) PHARMACOLOGICAL STRATEGIES FOR THE MANAGEMENT OF LEVODOPA-INDUCED DYSKINESIA IN PATIENTS WITH PARKINSON'S DISEASE.CNS DRUGS. VOL. 28. ISSUE 12. P. 1155 -1184 209 67% 6
4 NYHOLM, D , (2006) PHARMACOKINETIC OPTIMISATION IN THE TREATMENT OF PARKINSON'S DISEASE - AN UPDATE.CLINICAL PHARMACOKINETICS. VOL. 45. ISSUE 2. P. 109 -136 172 69% 98
5 JENNER, P , (2008) PREVENTING AND CONTROLLING DYSKINESIA IN PARKINSON'S DISEASE - A VIEW OF CURRENT KNOWLEDGE AND FUTURE OPPORTUNITIES.MOVEMENT DISORDERS. VOL. 23. ISSUE . P. S585-S598 139 77% 31
6 JENNER, P , (2008) MOLECULAR MECHANISMS OF L-DOPA-INDUCED DYSKINESIA.NATURE REVIEWS NEUROSCIENCE. VOL. 9. ISSUE 9. P. 665 -677 110 60% 229
7 JENNER, P , (2013) WEARING OFF, DYSKINESIA, AND THE USE OF CONTINUOUS DRUG DELIVERY IN PARKINSON'S DISEASE.NEUROLOGIC CLINICS. VOL. 31. ISSUE 3. P. S17-+ 91 88% 6
8 JOHNSTON, TH , LANE, EL , (2011) EXPERIMENTAL MODELS OF L-DOPA-INDUCED DYSKINESIA.PATHOPHYSIOLOGY, PHARMACOLOGY, AND BIOCHEMISTRY OF DYSKINESIA. VOL. 98. ISSUE . P. 55 -93 125 64% 1
9 VIJAYAKUMAR, D , JANKOVIC, J , (2016) DRUG-INDUCED DYSKINESIA, PART 1: TREATMENT OF LEVODOPA-INDUCED DYSKINESIA.DRUGS. VOL. 76. ISSUE 7. P. 759 -777 94 69% 1
10 BLANDINI, F , ARMENTERO, MT , (2014) DOPAMINE RECEPTOR AGONISTS FOR PARKINSON'S DISEASE.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 23. ISSUE 3. P. 387 -410 110 62% 7

Classes with closest relation at Level 1



Rank Class id link
1 13868 ENTACAPONE//TOLCAPONE//COMT INHIBITORS
2 29114 PRAMIPEXOLE//PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE//TALIPEXOLE
3 17072 VISUAL HALLUCINATIONS//HALLUCINATIONS//PARKINSONS DISEASE PSYCHOSIS
4 7937 SELEGILINE//RASAGILINE//DEPRENYL
5 3801 NON MOTOR SYMPTOMS//PARKINSONS DISEASE//PDQ 39
6 32888 CHRONIC BILATERAL SUBTHALAMIC STIMULATION//AUSTRALIA ESKITIS CELL MOL THER IES//ACUTE AND CHRONIC NEUROLOGICAL DISEASES
7 17206 IMPULSE CONTROL DISORDERS//DOPAMINE DYSREGULATION SYNDROME//PUNDING
8 8489 I 123 FP CIT//VASCULAR PARKINSONISM//DOPAMINE TRANSPORTER
9 36616 BUDIPINE//1 TERT BUTYL 4 4 DIPHENYLPIPERIDINE//ADENOSINE A2 ANTAGONISTS
10 30382 EOSINOPHILIC PLEURAL EFFUSION//PLEURAL FLUID EOSINOPHILIA//DRUG INDUCED ADVERSE EFFECTS IN LUNG

Go to start page